NDC 17856-0646-04 - AMANTADINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0646
- Requested NDC
- 17856-0646-04
- Package NDCs from labels
- 17856-0646-3, 17856-0646-1, 17856-0646-4, 17856-0646-2, 17856-0646-04
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amantadine Hydrochloride Oral Solution USP 50 mg/5 mL | ATLANTIC BIOLOGICALS CORP. | 2025-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 17856-0646-1 | 2024-04-08 | Amantadine Hydrochloride Oral Solution USP 50 mg/5 mL |
| 17856-0646-2 | 2024-04-08 | Amantadine Hydrochloride Oral Solution USP 50 mg/5 mL |
| 17856-0646-1 | 2024-01-30 | Amantadine Hydrochloride Oral Solution USP 50 mg/5 mL |
| 17856-0646-2 | 2024-01-30 | Amantadine Hydrochloride Oral Solution USP 50 mg/5 mL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0646-1 | AMANTADINE HYDROCHLORIDE | 72 in 1 BOX, UNIT-DOSE | SOLUTION | 72 | 4 | |
| 17856-0646-2 | AMANTADINE HYDROCHLORIDE | 72 in 1 PACKAGE | SOLUTION | 72 | 4 | |
| 17856-0646-3 | AMANTADINE HYDROCHLORIDE | 10 mL in 1 CUP, UNIT-DOSE | SOLUTION | 10 | 4 | |
| 17856-0646-4 | AMANTADINE HYDROCHLORIDE | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0646 | AMANTADINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20250514_6311b46b-23cc-40c1-93c2-f7c92606386f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0646-1 | ML - Milliliter | 17856-0646 | 131fab16-c40f-4017-b8e6-0450c9c3649f | 1 | 2025-06-13 |
| 17856-0646-2 | ML - Milliliter | 17856-0646 | 0f48881a-f29b-4b66-bb38-0ccada9cb37c | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dry eye relief | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | f8da3af5-9172-4023-be82-0fd5bd891616 | 2025-09-12 | Warnings | 6DC9Q167V3 |
| Medi-First First Aid Eye Wash | PURIFIED WATER | Unifirst First Aid Corporation | dcd7fe56-ff5c-4c8d-a415-6e363d7e53f4 | 2025-09-08 | Warnings | 059QF0KO0R |
| Green Guard First Aid Eye Wash | WATER | Unifirst First Aid Corporation | a4ba5526-b4e2-4bcc-9127-aa22ebf5017f | 2025-09-08 | Warnings | 059QF0KO0R |
| Medi-First Plus First Aid Eye Wash | WATER | Unifirst First Aid Corporation | d7ea80ca-b4a0-4476-8b50-b3425c6d456a | 2025-09-08 | Warnings | 059QF0KO0R |
| ECOLAB Eye Wash | PURIFIED WATER | ECOLAB Food Safety Specialties, Inc. | 4bcfa21a-791e-4d04-e054-00144ff88e88 | 2025-09-08 | Warnings | 059QF0KO0R |
| Physicians Care Eyewash | EYEWASH | Acme United Corporation | 3e239b12-9a75-339d-e063-6294a90a72ae | 2025-09-06 | Warnings | 059QF0KO0R |
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | ST. MARY'S MEDICAL PARK PHARMACY | 3dd7f2a6-5a91-81a2-e063-6294a90a33db | 2025-09-02 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Medique Medi Seltzer | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Unifirst First Aid Corporation | 528da9d9-2a52-4c16-b7b2-61b3eee1abea | 2025-08-19 | Warnings | 2968PHW8QP |
| Systane COMPLETE | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 2df0de02-a3e2-471a-9e10-040c3fba75fe | 2025-08-08 | Warnings | 6DC9Q167V3 |
| AMANTADINE HYDROCHLORIDE | AMANTADINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | be411327-5ac7-46df-b5e4-32a11b419b15 | 2025-08-07 | Warnings, Adverse reactions | ANDA074509 0121-0646 849385 0d5911e6-e5b6-4013-98ec-773d9ec62dec be411327-5ac7-46df-b5e4-32a11b419b15 M6Q1EO9TD0 |
| Systane Balance | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | c7b1a03a-a5f2-409e-a34a-d6f166671de5 | 2025-08-07 | Warnings | 6DC9Q167V3 |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 99b63d62-1cf0-4f28-8760-773917c2538a | 2025-07-29 | Warnings | 6DC9Q167V3 |
| Amantadine | AMANTADINE | Alembic Pharmaceuticals Inc. | da1837b5-fda2-48e0-91ba-d6eb2b991b55 | 2025-07-28 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| amantadine hydrochloride | AMANTADINE HYDROCHLORIDE | Bryant Ranch Prepack | 8e578f11-6112-4a1f-8de4-a76870bb62c7 | 2025-07-14 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | Advagen Pharma Limited | c3b9e7f0-be6d-4f37-9277-54bb0ba8b158 | 2025-07-09 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | Upsher-Smith Laboratories, LLC | 5232b933-1df9-43b4-8ac2-61bfa4855e68 | 2025-07-09 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| AMANTADINE HYDROCHLORIDE | AMANTADINE HYDROCHLORIDE | BAJAJ MEDICAL, LLC | 38fccce5-1f1e-9350-e063-6394a90a045a | 2025-07-02 | Warnings, Adverse reactions | 849385 M6Q1EO9TD0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.